{"ticker": {"uuid": "20499e09-3642-4f26-9d7b-e9ae555c94c1", "symbol": "ICU", "name": "SeaStar Medical Holding Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "KeyBanc raises ICU Medical stock price target on pump growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxObE5HTENKY0JQN2Y2V3FSWnVLbER3V3h4clREWFBzZEhNSExtNE9KYllqa1pkOXM3UDYycGZxb2hrV05ucG50SlRCcW1IakpyTjNObFVia3R4YVVtUHd2VnpwY25FTVRnaTdnSG5EWHEzbmgyaS1aMWJYclVNbXB3YWNsb0FPZzhhVlA0b25LUHFtNjFPR09qOTJabmNrQ2k5OGFCcnZ1bGVERU5FVG1icnlVUlkxUmNDenpGZA?oc=5", "source_name": "Investing.com", "published_at": "2026-07-21T12:59:06+00:00", "published_display": "21 Jul 2026 12:59", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Expands Austin IV Capacity, Is The Stock Already Pricey?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-20T09:26:37+00:00", "published_display": "20 Jul 2026 09:26", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "ICU Medical stock hits 52-week high at 162.53 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPU3E5eUs3N3pfajJ6TjhhVERxT2pIN1hKOG1vb0JTZ0NyblVnX2NyODdfU1cydHVxNC0yTThiUjVaTTBSdTJtdmF2Q1ZydHY3aXgwaEx3TGJuQ2U4N1g5bnB3ajJoNlpaX3dqZnZDU3Zla2MybjhIM2lwX3JuRlBaajBROFRsRDAxQ3N4OWpQUW5kX05JZWR4eXd0SmRyWTBWaTlPamhRWQ?oc=5", "source_name": "Investing.com", "published_at": "2026-07-16T13:51:37+00:00", "published_display": "16 Jul 2026 13:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will US$500 Million Non-DEHP IV Expansion in Texas Change ICU Medical's (ICUI) Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-15T20:47:51+00:00", "published_display": "15 Jul 2026 20:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/seastar-medical-supports-advances-critical-123400544.html", "source_name": "GlobeNewswire", "published_at": "2026-07-14T12:34:00+00:00", "published_display": "14 Jul 2026 12:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical sponsors pediatric kidney injury summit", "summary": "SeaStar Medical (NASDAQ: ICU) is sponsoring the KidneyBee Summit 2026 and an educational webinar to address pediatric acute kidney injury. The company's QUELIMMUNE therapy, approved for critically ill children with AKI and sepsis, has shown high survival rates in clinical trials.", "url": "https://www.investing.com/news/company-news/seastar-medical-sponsors-pediatric-kidney-injury-summit-93CH-4790872", "source_name": "Investing.com", "published_at": "2026-07-14T13:10:59", "published_display": "14 Jul 2026 13:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical: More Than 50% of Children With Severe Kidney Injury Die", "summary": "SeaStar Medical (Nasdaq: ICU) announced its sponsorship of key educational initiatives to improve critical care for pediatric patients suffering from acute kidney injury (AKI), a condition that tragically leads to the death of over 50% of affected children in ICUs. The company is", "url": "https://www.stocktitan.net/news/ICU/sea-star-medical-supports-advances-in-critical-care-of-pediatric-xvq6asbyyum5.html", "source_name": "Stock Titan", "published_at": "2026-07-14T12:11:00", "published_display": "14 Jul 2026 12:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "How ICU Medical plans to shore up U.S. IV solution supply", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNVGRDdVN5cy1zdVRtSS1IcUJiaEpJZzRmZlhUQmhNUnEwV2VoWEFTdDI3UFhESGxwMTVRa3lCVVk5UjNqWU5rU2dIVTNIc0pxcTg0NzN3UGM3Tkp4elhBWmRuWDkxR2xETHdVdXMxNTdrV0h6TXZFbVMwWHZNcC1HRUZRVnlCV04xdVhsazZNM2hHN0oyQ1RnbVhOZTlLMi16Y0JmcFZUQ1hiUjM3VjZzc1dIXzNUWDFQQzBGZVdLQTM?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "4,000-share RSU grant to SeaStar Medical (ICU) director disclosed", "summary": "SeaStar Medical Holding Corp. (ICU) director Bernadette N. Vincent was granted 4,000 restricted stock units (RSUs) on July 1, 2026, which will vest in full on July 1, 2027. The grant was awarded at $0.00 per share, indicating a compensation grant rather than a purchase. This tran", "url": "https://www.stocktitan.net/sec-filings/ICU/form-4-sea-star-medical-holding-corp-insider-trading-activity-e2cba6a21531.html", "source_name": "Stock Titan", "published_at": "2026-07-03T02:10:55", "published_display": "03 Jul 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (NASDAQ: ICU) director receives 4,000 restricted stock units", "summary": "SeaStar Medical (NASDAQ: ICU) director Jennifer A. Baird was granted 4,000 restricted stock units (RSUs) which will fully vest on July 1, 2027. Following this award, her direct holdings in the company's common stock now total 10,620 shares. This transaction was reported in a Form", "url": "https://www.stocktitan.net/sec-filings/ICU/form-4-sea-star-medical-holding-corp-insider-trading-activity-6b2897a9f106.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:11:48", "published_display": "02 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) director granted 4,000 restricted stock units", "summary": "SeaStar Medical (ICU) director Kenneth Van Heel was granted 4,000 Restricted Stock Units (RSUs) on July 1, 2026. These RSUs will fully vest on July 1, 2027, provided he remains eligible. Following this grant, Van Heel directly holds 11,940 shares of the company's common stock.", "url": "https://www.stocktitan.net/sec-filings/ICU/form-4-sea-star-medical-holding-corp-insider-trading-activity-246a44303268.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:11:48", "published_display": "02 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 SeaStar Medical Holding Corp For: 2 July By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for SeaStar Medical Holding Corp for the date of July 2nd. The content appears to be a brief announcement with financial market data and popular news headlines, but does not contain detailed information about the Form 4 i", "url": "https://ca.investing.com/news/stock-market-news/form-4-seastar-medical-holding-corp-for-2-july-93CH-4719148", "source_name": "Investing.com Canada", "published_at": "2026-07-02T21:11:48", "published_display": "02 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) CEO receives 10,288 restricted stock units in equity grant", "summary": "SeaStar Medical Holding Corp's CEO, Eric Schlorff, has been granted 10,288 restricted stock units (RSUs) as an equity award, not an open-market purchase. These RSUs, valued at $0.00 per share, will vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2", "url": "https://www.stocktitan.net/sec-filings/ICU/form-4-sea-star-medical-holding-corp-insider-trading-activity-9c3b01e5ef48.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:11:48", "published_display": "02 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) director awarded 4,000 RSUs, holdings now 16,200 shares", "summary": "SeaStar Medical director John Neuman was awarded 4,000 Restricted Stock Units (RSUs) as compensation, not through an open-market purchase. These RSUs will fully vest on July 1, 2027. Following this grant, Neuman's total holdings in SeaStar Medical common stock now stand at 16,200", "url": "https://www.stocktitan.net/sec-filings/ICU/form-4-sea-star-medical-holding-corp-insider-trading-activity-79ce16e57147.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:11:48", "published_display": "02 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) adopts 2026 retention bonus program for top executives", "summary": "SeaStar Medical Holding Corporation has approved a 2026 Retention Bonus Program for executives Eric Schlorff ($200,000) and Kevin Chung ($140,000). The bonuses will be paid in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027, subject to continued empl", "url": "https://www.stocktitan.net/sec-filings/ICU/8-k-sea-star-medical-holding-corp-reports-material-event-d7ca2d2c676c.html", "source_name": "Stock Titan", "published_at": "2026-07-01T19:39:15", "published_display": "01 Jul 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) grants CMO 7,202 restricted stock units", "summary": "SeaStar Medical Holding Corp. has granted its Chief Medical Officer, Kevin Chung, 7,202 restricted stock units (RSUs) as part of his compensation, at no cash cost to him. These RSUs will vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027, bringi", "url": "https://www.stocktitan.net/sec-filings/ICU/form-4-sea-star-medical-holding-corp-insider-trading-activity-0cf98c301e02.html", "source_name": "Stock Titan", "published_at": "2026-06-30T08:11:39", "published_display": "30 Jun 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI): Buy, Sell, or Hold Post Q1 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPUnM3WjBFYzVySERDVmI0TjFlTC13anlITGhUZTQ3Um9Fam9haWEyZzVCZUZRbUZ4d2hxYjgyU1YyMTVtVGVUOW1FZFB6bkpCMXRTMGJsLW1DSGRDM3VHTW5aeG5nbXZYVHBLRHk0VHdReGFhaXVqckpEdzliMjY2dWJBdm44alBfMjlPSlpfRzBtM3Jn?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury", "summary": "SeaStar Medical (Nasdaq: ICU) announced the acquisition of dedicated ICD-10-PCS codes from the Centers for Medicare & Medicaid Services (CMS) for its Selective Cytopheretic Device (SCD) therapy. These codes will enable standardized inpatient hospital billing and reporting for the", "url": "https://finance.yahoo.com/healthcare/articles/seastar-medical-announces-icd-10-122500592.html", "source_name": "Market source", "published_at": "2026-06-23T22:11:25", "published_display": "23 Jun 2026 22:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (NASDAQ: ICU) amends Mr. Green separation deal", "summary": "SeaStar Medical Holding Corporation (NASDAQ: ICU) filed an amended 8-K report clarifying a new separation and release agreement with Mr. Green, entered into on June 10, 2026. This amendment updates terms related to his disputed not-for-cause termination, with SeaStar Medical agre", "url": "https://www.stocktitan.net/sec-filings/ICU/8-k-a-sea-star-medical-holding-corp-amends-material-event-report-5509b6f5410b.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:42:38", "published_display": "23 Jun 2026 20:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hospitals get new billing codes for SeaStar Medical\u2019s kidney therapy", "summary": "SeaStar Medical (Nasdaq: ICU) announced that its Selective Cytopheretic Device (SCD) therapy for acute kidney injury requiring renal replacement therapy has received dedicated ICD-10-PCS codes from the Centers for Medicare & Medicaid Services (CMS). These new codes, effective Oct", "url": "https://www.stocktitan.net/news/ICU/sea-star-medical-announces-new-icd-10-pcs-codes-for-its-scd-therapy-ytxhh1d1solx.html", "source_name": "Stock Titan", "published_at": "2026-06-23T12:42:39", "published_display": "23 Jun 2026 12:42", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICUCW) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of SeaStar Medical Holding Corp (ICUCW), detailing its current stock price, market capitalization, and various technical indicators. The analysis shows a prevailing \"Sell\" signal based on both technical indicators and moving averages, wi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icucw/technical", "source_name": "TradingKey", "published_at": "2026-06-23T12:09:48", "published_display": "23 Jun 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical to Present at Upcoming Investor Summit Conference", "summary": "SeaStar Medical Holding Corporation announced that CEO Eric Schlorff will present at the Virtual Investor Summit Conference on June 24th at 10:30 am Eastern Time. The company, focused on treatments for critically ill patients, recently received FDA approval for QUELIMMUNE\u00ae (SCD-P", "url": "https://finance.yahoo.com/healthcare/articles/seastar-medical-present-upcoming-investor-124500874.html", "source_name": "Market source", "published_at": "2026-06-22T12:39:29", "published_display": "22 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical CEO to present at virtual investor summit June 24", "summary": "SeaStar Medical (Nasdaq: ICU) announced that CEO Eric Schlorff will present at the Virtual Investor Summit Conference on June 24, 2026, at 10:30 a.m. Eastern Time. The company, a commercial-stage healthcare firm, focuses on treatments for critically ill patients with organ failur", "url": "https://www.stocktitan.net/news/ICU/sea-star-medical-to-present-at-upcoming-investor-summit-h7bc4gt5mbv2.html", "source_name": "Stock Titan", "published_at": "2026-06-22T12:39:29", "published_display": "22 Jun 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICUCW) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis for SeaStar Medical Holding Corp (ICUCW), focusing on its PE, PB, P/S, and P/CF ratios. The analysis indicates that relevant data for these metrics have not yet been disclosed by the company. TradingKey provides this financial informatio", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icucw/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-19T11:10:26", "published_display": "19 Jun 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICUCW) Institutional Confidence", "summary": "This article provides details on the institutional confidence in SeaStar Medical Holding Corp (ICUCW), including its stock price, market cap, and a breakdown of institutional shareholdings. The data shows key institutional investors and their changes in shares held, with some fir", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icucw/sentiment", "source_name": "TradingKey", "published_at": "2026-06-19T11:10:25", "published_display": "19 Jun 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp", "summary": "This article provides an overview of SeaStar Medical Holding Corp (ICU), including its current stock price and key financial metrics like market capitalization. It indicates that detailed revenue breakdown by business segment and region has not yet been disclosed by the company. ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icu/revenue", "source_name": "TradingKey", "published_at": "2026-06-19T08:11:38", "published_display": "19 Jun 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICUCW) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article from TradingKey provides an overview of SeaStar Medical Holding Corp's (ICUCW) financial health, specifically focusing on profitability and balance sheet analysis. It notes that relevant financial data for key metrics such as cash and equivalents, total assets, liabi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icucw/financial-health", "source_name": "TradingKey", "published_at": "2026-06-19T08:10:26", "published_display": "19 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical shareholders approve equity plan expansion and board election", "summary": "SeaStar Medical shareholders have approved all proposals at their annual meeting, including the election of John Neuman as a Class I director and an amendment to expand the company's 2022 Omnibus Incentive Plan. They also ratified the appointment of WithumSmith+Brown, PC as their", "url": "https://www.investing.com/news/sec-filings/seastar-medical-shareholders-approve-equity-plan-expansion-and-board-election-93CH-4748758", "source_name": "Investing.com", "published_at": "2026-06-18T21:39:29", "published_display": "18 Jun 2026 21:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICU) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of SeaStar Medical Holding Corp (ICU), detailing its price momentum score within the Healthcare Equipment & Supplies industry. It identifies current support and resistance levels, and presents a comprehensive overview of various technica", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icu/technical", "source_name": "TradingKey", "published_at": "2026-06-18T20:39:50", "published_display": "18 Jun 2026 20:39", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICU) Institutional Confidence", "summary": "This article from TradingKey provides an overview of SeaStar Medical Holding Corp's (ICU) institutional confidence and shareholding activity as of June 18, 2026. It lists several institutional investors and individual shareholders, along with their shares held and the percentage ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icu/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T20:10:26", "published_display": "18 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical shareholders approve equity plan expansion and board election By Investing.com", "summary": "SeaStar Medical shareholders approved all proposals at their annual meeting, including the election of John Neuman as a Class I director and an expansion of the company's 2022 Omnibus Incentive Plan. The amendment increases authorized shares under the plan from 207,046 to 896,546", "url": "https://m.za.investing.com/news/sec-filings/seastar-medical-shareholders-approve-equity-plan-expansion-and-board-election-93CH-4334176?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-06-18T06:40:02", "published_display": "18 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICUCW) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of SeaStar Medical Holding Corp (ICUCW) regarding its historical dividend payouts and stock splits. It states that the company has distributed a total of 0.00 USD in dividends over the past five years and contains no data for specific dividend or", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icucw/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:48", "published_display": "18 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICU) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "SeaStar Medical Holding Corp (ICU) has an earnings forecast score of 8.00, placing it 66th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $1.00 with a \"Buy\" rating. The company's expected revenue for the next quarter is $486.50K, and", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icu/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T21:39:48", "published_display": "17 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (NASDAQ: ICU) boosts equity plan share reserve at 2026 meeting", "summary": "SeaStar Medical Holding Corporation announced the results of its annual stockholder meeting held on June 17, 2026. Stockholders approved an amendment to the 2022 Omnibus Incentive Plan, significantly increasing the authorized shares of common stock for equity-based compensation f", "url": "https://www.stocktitan.net/sec-filings/ICU/8-k-sea-star-medical-holding-corp-reports-material-event-712a5b3b27de.html", "source_name": "Stock Titan", "published_at": "2026-06-17T19:39:48", "published_display": "17 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Stock Valuation Check After Recent Momentum And Discount To Estimated Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQeDZjdVU3Ulh0dHViWVpRdk1OdnpFSlhkZjZwMTdSeUdBdVBYSWN0ZGFEZHFEaVk4UmsybW1uRklVZmtoZ19UMFhsLUZvZTVyWUlVbDZwNmFBT1N2UExGMkVnZ0pCNVFtMlZBZ3M5SGc2UDY4Qm9DYnpoUHdJeThScTVlUnY5Q05PdGdsXzh0YlZ4MWpOUDMzZVFQMlJRZw?oc=5", "source_name": "Market source", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "SeaStar Medical Holding Corporation Q2 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/789d7308-f055-3206-afc8-86e7816aaf68/seastar-medical-holding.html", "source_name": "Moby", "published_at": "2026-05-14T12:30:00+00:00", "published_display": "14 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "SeaStar Medical Holding Corp (ICU) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/seastar-medical-holding-corp-icu-050151895.html", "source_name": "GuruFocus.com", "published_at": "2026-05-14T05:01:51+00:00", "published_display": "14 May 2026 05:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/f8ebff92-8c16-307e-8f58-82d0922cd989/seastar-medical-%28icu%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-13T21:48:05+00:00", "published_display": "13 May 2026 21:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Full Transcript: SeaStar Medical Holding Q1 2026 Earnings Call", "summary": "", "url": "https://finance.yahoo.com/news/full-transcript-seastar-medical-holding-212042506.html", "source_name": "Benzinga", "published_at": "2026-05-13T21:20:42+00:00", "published_display": "13 May 2026 21:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar device data suggest fewer child kidney deaths in early use", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQbkpvMGVhdGZOdlBvYVN1b0VNZGlCRjZORkR5T1lwTTFVY3lUVWZhSEdWdXkxOWtlY1JRNV9WVXRMY1FISFBQbWNxN0pMRWMxU01tZUNLSlgwd3l2SmxBd2xGc3h1a2txb1JkQllRTWpJd0dUMnRkWVdXQ0RybmFWLW1rWTlZRUdRSEE3MzJUZWNRZUF4NFh5YlAzNXhNSGJJcmtVNDR2djFoRWY0U1BuQV9oVDI?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Implied Volatility Surging for ICU Medical Stock Options", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPU3EyenkxUTdLZm53Qlp6ZjRMX2J3UUJVaVEzd2FBcjV6bTJUT25NdzczSWpqSFFJVjE0WHVIeGc3dUVUbGRDZzExYlN1cm11Sm8wbjlfNUJhNlBqV3p3ZVk5VGhrRVA2UXExeFROUU9aWEJBZmVWY2JickxEeElUZ3E2TWRWUU9BcVJtajM4U05LX19IZXVnSFh6T3VjZ2JsRF94MTJNVQ?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOMHZhOWJhTGNOYlFHazhRaW1Cb3I1M01IQVFrZExhRk8tTWk3QmM3MFFnSXBGV1lIRXIxeVluRk1EaERHdTUzVHRZSEFyRzZLVmJCRVJlS0RTWlFyakRqNWExVDUzSm1ZUWxVZkxSdzdmWk5HV1o0MzQwY2d1S1RGUTBjOTlNeVc3dkQwd2NyYk9VMFZEUmt6LQ?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical sets May 13 webcast for Q1 results and update", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQcnFQTkZRQUFnODFHeEphZWJWX0tDcEo1Vks5aXVHTXNXRldjRmVxN2hFd1oxeExfcVFsUUt1NTctTk1XYldIelJUd1JHNDlIaDNWR1JpY05TTUhmX0wtdk9TOVhKZlNoSWhfTm8yTXk2enN5aGt3bnQ1ZjREWDJOQ0ZHVW5ZblhNQk5FcF9EMUwxMEd1eUdPS0FuSVU3TVp4VHo2aV84Y3NPVTg3bFZPX2JiOTBJRGZPNUNMT3ZqZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQbzBJT3c3X3RKczlqVkpoLVY4MGdVZXN4VnlnWkZycWx3XzdiVlNhTTNaTjE3N005TGJEWVgyNTM0d2hVYTlsdUQxZU1za1pHVm5SR3pkWUtyaHMyU3VVSWJsWXhKVWMydllsVjYtdG41aWpDX3MzR0RWa2pxNXRBcldaMDFrWk1sVnpKb21xRnlYUzFROUpmbDN3?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "13 more children's hospitals adopt SeaStar therapy as AKI trial tops 50%", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPamljZFl3UE9kbXZFdnlnZXhYUEI2dG13aThFSUE1NXVJY3ozTDU5YjUzWW8wV3hwRjJZa3U0cHloNFpTS2tPWnMxR0N6anhuOHptMHBmUWowOGRIUk1RWlNsSjd2RTh5eFluZlVmcGNxX3lDWUpwM1VWNkVuZHFDRk5xbDhaalR2ZlU4REJzZmZ2bGNScGVsNDR4QUpULTJPVmROMXhfRFliYVhnSXF2dnJIYlhmcDFRVTlSWG1tSQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The ICU Medical (ICUI) Investment Story Is Evolving With 2026 Guidance And Analyst Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNbjZJTWNZcnZmbnJhMXRPOWFMMFNuQ2xYQ3o3N1hDUTVuNVdicDNPeGxMdkl4ZFNiV08zNGY3OXFfOVFuU3diRXZCSTZ4NUVzVHd0blNSYWwwXzVxUzJoV3J4RUdCUkdfNnJQeURoUEhCNnBITHc2dk5FVXNGWkxIcEZ4dm9lSHU4QzQ1Y2lBaXMwS1AzQWNiM3B1dFBUdmc?oc=5", "source_name": "Market source", "published_at": "2026-03-22T07:00:00+00:00", "published_display": "22 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $ICU", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBqbEN5d2RTbXA4aWw5ZHh5UEZBbW5Ja054N3NxWFB5SnJYNXdvaF82TzFsdU5DUU93aDB2QzdHY01YOXNBZ1M2OElTX3FHQ0h5clpmcV9wV2JTRWJkM0x1M1Q5bDFfQ2c?oc=5", "source_name": "MarketBeat", "published_at": "2025-07-09T20:09:50+00:00", "published_display": "09 Jul 2025 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding (ICU) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE8zSjgxbFdKNUMzLU9xeHEzWU1XQzgyQnJnci1qajZGaTlKaFpXWk1ad3FwYjFpOEZ1SFF0Nlp3cUh5czcxdkVJcEpKX2ZqbEtJYkE?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T01:46:39+00:00", "published_display": "25 Apr 2025 01:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SEASTAR ALERT: Bragar Eagel & Squire, P.C. Announces that a", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "GlobeNewswire", "published_at": "2024-07-09T07:00:00+00:00", "published_display": "09 Jul 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) Stock Price, News & Analysis $ICU", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE96ZUdPcjJIUXNyaW1FSjg1c2xKeDZZQjNSbVVQdHhmWDFLOENfWk9XYURseERCUktxVDdCdWMwS054MS1DZEJ1TkVFcnZiV2xMeFcwM3pxT3E?oc=5", "source_name": "MarketBeat", "published_at": "2022-11-02T10:02:15+00:00", "published_display": "02 Nov 2022 10:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "KeyBanc raises ICU Medical stock price target on pump growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxObE5HTENKY0JQN2Y2V3FSWnVLbER3V3h4clREWFBzZEhNSExtNE9KYllqa1pkOXM3UDYycGZxb2hrV05ucG50SlRCcW1IakpyTjNObFVia3R4YVVtUHd2VnpwY25FTVRnaTdnSG5EWHEzbmgyaS1aMWJYclVNbXB3YWNsb0FPZzhhVlA0b25LUHFtNjFPR09qOTJabmNrQ2k5OGFCcnZ1bGVERU5FVG1icnlVUlkxUmNDenpGZA?oc=5", "source_name": "Investing.com", "published_at": "2026-07-21T12:59:06+00:00", "published_display": "21 Jul 2026 12:59", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Expands Austin IV Capacity, Is The Stock Already Pricey?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-20T09:26:37+00:00", "published_display": "20 Jul 2026 09:26", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical stock hits 52-week high at 162.53 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPU3E5eUs3N3pfajJ6TjhhVERxT2pIN1hKOG1vb0JTZ0NyblVnX2NyODdfU1cydHVxNC0yTThiUjVaTTBSdTJtdmF2Q1ZydHY3aXgwaEx3TGJuQ2U4N1g5bnB3ajJoNlpaX3dqZnZDU3Zla2MybjhIM2lwX3JuRlBaajBROFRsRDAxQ3N4OWpQUW5kX05JZWR4eXd0SmRyWTBWaTlPamhRWQ?oc=5", "source_name": "Investing.com", "published_at": "2026-07-16T13:51:37+00:00", "published_display": "16 Jul 2026 13:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will US$500 Million Non-DEHP IV Expansion in Texas Change ICU Medical's (ICUI) Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-15T20:47:51+00:00", "published_display": "15 Jul 2026 20:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/seastar-medical-supports-advances-critical-123400544.html", "source_name": "GlobeNewswire", "published_at": "2026-07-14T12:34:00+00:00", "published_display": "14 Jul 2026 12:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical sponsors pediatric kidney injury summit", "summary": "SeaStar Medical (NASDAQ: ICU) is sponsoring the KidneyBee Summit 2026 and an educational webinar to address pediatric acute kidney injury. The company's QUELIMMUNE therapy, approved for critically ill children with AKI and sepsis, has shown high survival rates in clinical trials.", "url": "https://www.investing.com/news/company-news/seastar-medical-sponsors-pediatric-kidney-injury-summit-93CH-4790872", "source_name": "Investing.com", "published_at": "2026-07-14T13:10:59", "published_display": "14 Jul 2026 13:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical: More Than 50% of Children With Severe Kidney Injury Die", "summary": "SeaStar Medical (Nasdaq: ICU) announced its sponsorship of key educational initiatives to improve critical care for pediatric patients suffering from acute kidney injury (AKI), a condition that tragically leads to the death of over 50% of affected children in ICUs. The company is", "url": "https://www.stocktitan.net/news/ICU/sea-star-medical-supports-advances-in-critical-care-of-pediatric-xvq6asbyyum5.html", "source_name": "Stock Titan", "published_at": "2026-07-14T12:11:00", "published_display": "14 Jul 2026 12:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How ICU Medical plans to shore up U.S. IV solution supply", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNVGRDdVN5cy1zdVRtSS1IcUJiaEpJZzRmZlhUQmhNUnEwV2VoWEFTdDI3UFhESGxwMTVRa3lCVVk5UjNqWU5rU2dIVTNIc0pxcTg0NzN3UGM3Tkp4elhBWmRuWDkxR2xETHdVdXMxNTdrV0h6TXZFbVMwWHZNcC1HRUZRVnlCV04xdVhsazZNM2hHN0oyQ1RnbVhOZTlLMi16Y0JmcFZUQ1hiUjM3VjZzc1dIXzNUWDFQQzBGZVdLQTM?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "4,000-share RSU grant to SeaStar Medical (ICU) director disclosed", "summary": "SeaStar Medical Holding Corp. (ICU) director Bernadette N. Vincent was granted 4,000 restricted stock units (RSUs) on July 1, 2026, which will vest in full on July 1, 2027. The grant was awarded at $0.00 per share, indicating a compensation grant rather than a purchase. This tran", "url": "https://www.stocktitan.net/sec-filings/ICU/form-4-sea-star-medical-holding-corp-insider-trading-activity-e2cba6a21531.html", "source_name": "Stock Titan", "published_at": "2026-07-03T02:10:55", "published_display": "03 Jul 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (NASDAQ: ICU) director receives 4,000 restricted stock units", "summary": "SeaStar Medical (NASDAQ: ICU) director Jennifer A. Baird was granted 4,000 restricted stock units (RSUs) which will fully vest on July 1, 2027. Following this award, her direct holdings in the company's common stock now total 10,620 shares. This transaction was reported in a Form", "url": "https://www.stocktitan.net/sec-filings/ICU/form-4-sea-star-medical-holding-corp-insider-trading-activity-6b2897a9f106.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:11:48", "published_display": "02 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) director granted 4,000 restricted stock units", "summary": "SeaStar Medical (ICU) director Kenneth Van Heel was granted 4,000 Restricted Stock Units (RSUs) on July 1, 2026. These RSUs will fully vest on July 1, 2027, provided he remains eligible. Following this grant, Van Heel directly holds 11,940 shares of the company's common stock.", "url": "https://www.stocktitan.net/sec-filings/ICU/form-4-sea-star-medical-holding-corp-insider-trading-activity-246a44303268.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:11:48", "published_display": "02 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 SeaStar Medical Holding Corp For: 2 July By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for SeaStar Medical Holding Corp for the date of July 2nd. The content appears to be a brief announcement with financial market data and popular news headlines, but does not contain detailed information about the Form 4 i", "url": "https://ca.investing.com/news/stock-market-news/form-4-seastar-medical-holding-corp-for-2-july-93CH-4719148", "source_name": "Investing.com Canada", "published_at": "2026-07-02T21:11:48", "published_display": "02 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) CEO receives 10,288 restricted stock units in equity grant", "summary": "SeaStar Medical Holding Corp's CEO, Eric Schlorff, has been granted 10,288 restricted stock units (RSUs) as an equity award, not an open-market purchase. These RSUs, valued at $0.00 per share, will vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2", "url": "https://www.stocktitan.net/sec-filings/ICU/form-4-sea-star-medical-holding-corp-insider-trading-activity-9c3b01e5ef48.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:11:48", "published_display": "02 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) director awarded 4,000 RSUs, holdings now 16,200 shares", "summary": "SeaStar Medical director John Neuman was awarded 4,000 Restricted Stock Units (RSUs) as compensation, not through an open-market purchase. These RSUs will fully vest on July 1, 2027. Following this grant, Neuman's total holdings in SeaStar Medical common stock now stand at 16,200", "url": "https://www.stocktitan.net/sec-filings/ICU/form-4-sea-star-medical-holding-corp-insider-trading-activity-79ce16e57147.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:11:48", "published_display": "02 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) adopts 2026 retention bonus program for top executives", "summary": "SeaStar Medical Holding Corporation has approved a 2026 Retention Bonus Program for executives Eric Schlorff ($200,000) and Kevin Chung ($140,000). The bonuses will be paid in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027, subject to continued empl", "url": "https://www.stocktitan.net/sec-filings/ICU/8-k-sea-star-medical-holding-corp-reports-material-event-d7ca2d2c676c.html", "source_name": "Stock Titan", "published_at": "2026-07-01T19:39:15", "published_display": "01 Jul 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) grants CMO 7,202 restricted stock units", "summary": "SeaStar Medical Holding Corp. has granted its Chief Medical Officer, Kevin Chung, 7,202 restricted stock units (RSUs) as part of his compensation, at no cash cost to him. These RSUs will vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027, bringi", "url": "https://www.stocktitan.net/sec-filings/ICU/form-4-sea-star-medical-holding-corp-insider-trading-activity-0cf98c301e02.html", "source_name": "Stock Titan", "published_at": "2026-06-30T08:11:39", "published_display": "30 Jun 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI): Buy, Sell, or Hold Post Q1 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPUnM3WjBFYzVySERDVmI0TjFlTC13anlITGhUZTQ3Um9Fam9haWEyZzVCZUZRbUZ4d2hxYjgyU1YyMTVtVGVUOW1FZFB6bkpCMXRTMGJsLW1DSGRDM3VHTW5aeG5nbXZYVHBLRHk0VHdReGFhaXVqckpEdzliMjY2dWJBdm44alBfMjlPSlpfRzBtM3Jn?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury", "summary": "SeaStar Medical (Nasdaq: ICU) announced the acquisition of dedicated ICD-10-PCS codes from the Centers for Medicare & Medicaid Services (CMS) for its Selective Cytopheretic Device (SCD) therapy. These codes will enable standardized inpatient hospital billing and reporting for the", "url": "https://finance.yahoo.com/healthcare/articles/seastar-medical-announces-icd-10-122500592.html", "source_name": "Market source", "published_at": "2026-06-23T22:11:25", "published_display": "23 Jun 2026 22:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (NASDAQ: ICU) amends Mr. Green separation deal", "summary": "SeaStar Medical Holding Corporation (NASDAQ: ICU) filed an amended 8-K report clarifying a new separation and release agreement with Mr. Green, entered into on June 10, 2026. This amendment updates terms related to his disputed not-for-cause termination, with SeaStar Medical agre", "url": "https://www.stocktitan.net/sec-filings/ICU/8-k-a-sea-star-medical-holding-corp-amends-material-event-report-5509b6f5410b.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:42:38", "published_display": "23 Jun 2026 20:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hospitals get new billing codes for SeaStar Medical\u2019s kidney therapy", "summary": "SeaStar Medical (Nasdaq: ICU) announced that its Selective Cytopheretic Device (SCD) therapy for acute kidney injury requiring renal replacement therapy has received dedicated ICD-10-PCS codes from the Centers for Medicare & Medicaid Services (CMS). These new codes, effective Oct", "url": "https://www.stocktitan.net/news/ICU/sea-star-medical-announces-new-icd-10-pcs-codes-for-its-scd-therapy-ytxhh1d1solx.html", "source_name": "Stock Titan", "published_at": "2026-06-23T12:42:39", "published_display": "23 Jun 2026 12:42", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICUCW) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of SeaStar Medical Holding Corp (ICUCW), detailing its current stock price, market capitalization, and various technical indicators. The analysis shows a prevailing \"Sell\" signal based on both technical indicators and moving averages, wi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icucw/technical", "source_name": "TradingKey", "published_at": "2026-06-23T12:09:48", "published_display": "23 Jun 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical to Present at Upcoming Investor Summit Conference", "summary": "SeaStar Medical Holding Corporation announced that CEO Eric Schlorff will present at the Virtual Investor Summit Conference on June 24th at 10:30 am Eastern Time. The company, focused on treatments for critically ill patients, recently received FDA approval for QUELIMMUNE\u00ae (SCD-P", "url": "https://finance.yahoo.com/healthcare/articles/seastar-medical-present-upcoming-investor-124500874.html", "source_name": "Market source", "published_at": "2026-06-22T12:39:29", "published_display": "22 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical CEO to present at virtual investor summit June 24", "summary": "SeaStar Medical (Nasdaq: ICU) announced that CEO Eric Schlorff will present at the Virtual Investor Summit Conference on June 24, 2026, at 10:30 a.m. Eastern Time. The company, a commercial-stage healthcare firm, focuses on treatments for critically ill patients with organ failur", "url": "https://www.stocktitan.net/news/ICU/sea-star-medical-to-present-at-upcoming-investor-summit-h7bc4gt5mbv2.html", "source_name": "Stock Titan", "published_at": "2026-06-22T12:39:29", "published_display": "22 Jun 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICUCW) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis for SeaStar Medical Holding Corp (ICUCW), focusing on its PE, PB, P/S, and P/CF ratios. The analysis indicates that relevant data for these metrics have not yet been disclosed by the company. TradingKey provides this financial informatio", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icucw/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-19T11:10:26", "published_display": "19 Jun 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICUCW) Institutional Confidence", "summary": "This article provides details on the institutional confidence in SeaStar Medical Holding Corp (ICUCW), including its stock price, market cap, and a breakdown of institutional shareholdings. The data shows key institutional investors and their changes in shares held, with some fir", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icucw/sentiment", "source_name": "TradingKey", "published_at": "2026-06-19T11:10:25", "published_display": "19 Jun 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp", "summary": "This article provides an overview of SeaStar Medical Holding Corp (ICU), including its current stock price and key financial metrics like market capitalization. It indicates that detailed revenue breakdown by business segment and region has not yet been disclosed by the company. ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icu/revenue", "source_name": "TradingKey", "published_at": "2026-06-19T08:11:38", "published_display": "19 Jun 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICUCW) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article from TradingKey provides an overview of SeaStar Medical Holding Corp's (ICUCW) financial health, specifically focusing on profitability and balance sheet analysis. It notes that relevant financial data for key metrics such as cash and equivalents, total assets, liabi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icucw/financial-health", "source_name": "TradingKey", "published_at": "2026-06-19T08:10:26", "published_display": "19 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical shareholders approve equity plan expansion and board election", "summary": "SeaStar Medical shareholders have approved all proposals at their annual meeting, including the election of John Neuman as a Class I director and an amendment to expand the company's 2022 Omnibus Incentive Plan. They also ratified the appointment of WithumSmith+Brown, PC as their", "url": "https://www.investing.com/news/sec-filings/seastar-medical-shareholders-approve-equity-plan-expansion-and-board-election-93CH-4748758", "source_name": "Investing.com", "published_at": "2026-06-18T21:39:29", "published_display": "18 Jun 2026 21:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICU) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of SeaStar Medical Holding Corp (ICU), detailing its price momentum score within the Healthcare Equipment & Supplies industry. It identifies current support and resistance levels, and presents a comprehensive overview of various technica", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icu/technical", "source_name": "TradingKey", "published_at": "2026-06-18T20:39:50", "published_display": "18 Jun 2026 20:39", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICU) Institutional Confidence", "summary": "This article from TradingKey provides an overview of SeaStar Medical Holding Corp's (ICU) institutional confidence and shareholding activity as of June 18, 2026. It lists several institutional investors and individual shareholders, along with their shares held and the percentage ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icu/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T20:10:26", "published_display": "18 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical shareholders approve equity plan expansion and board election By Investing.com", "summary": "SeaStar Medical shareholders approved all proposals at their annual meeting, including the election of John Neuman as a Class I director and an expansion of the company's 2022 Omnibus Incentive Plan. The amendment increases authorized shares under the plan from 207,046 to 896,546", "url": "https://m.za.investing.com/news/sec-filings/seastar-medical-shareholders-approve-equity-plan-expansion-and-board-election-93CH-4334176?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-06-18T06:40:02", "published_display": "18 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICUCW) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of SeaStar Medical Holding Corp (ICUCW) regarding its historical dividend payouts and stock splits. It states that the company has distributed a total of 0.00 USD in dividends over the past five years and contains no data for specific dividend or", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icucw/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:48", "published_display": "18 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICU) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "SeaStar Medical Holding Corp (ICU) has an earnings forecast score of 8.00, placing it 66th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $1.00 with a \"Buy\" rating. The company's expected revenue for the next quarter is $486.50K, and", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-icu/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T21:39:48", "published_display": "17 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (NASDAQ: ICU) boosts equity plan share reserve at 2026 meeting", "summary": "SeaStar Medical Holding Corporation announced the results of its annual stockholder meeting held on June 17, 2026. Stockholders approved an amendment to the 2022 Omnibus Incentive Plan, significantly increasing the authorized shares of common stock for equity-based compensation f", "url": "https://www.stocktitan.net/sec-filings/ICU/8-k-sea-star-medical-holding-corp-reports-material-event-712a5b3b27de.html", "source_name": "Stock Titan", "published_at": "2026-06-17T19:39:48", "published_display": "17 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Stock Valuation Check After Recent Momentum And Discount To Estimated Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQeDZjdVU3Ulh0dHViWVpRdk1OdnpFSlhkZjZwMTdSeUdBdVBYSWN0ZGFEZHFEaVk4UmsybW1uRklVZmtoZ19UMFhsLUZvZTVyWUlVbDZwNmFBT1N2UExGMkVnZ0pCNVFtMlZBZ3M5SGc2UDY4Qm9DYnpoUHdJeThScTVlUnY5Q05PdGdsXzh0YlZ4MWpOUDMzZVFQMlJRZw?oc=5", "source_name": "Market source", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corporation Q2 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/789d7308-f055-3206-afc8-86e7816aaf68/seastar-medical-holding.html", "source_name": "Moby", "published_at": "2026-05-14T12:30:00+00:00", "published_display": "14 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding Corp (ICU) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/seastar-medical-holding-corp-icu-050151895.html", "source_name": "GuruFocus.com", "published_at": "2026-05-14T05:01:51+00:00", "published_display": "14 May 2026 05:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/f8ebff92-8c16-307e-8f58-82d0922cd989/seastar-medical-%28icu%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-13T21:48:05+00:00", "published_display": "13 May 2026 21:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Full Transcript: SeaStar Medical Holding Q1 2026 Earnings Call", "summary": "", "url": "https://finance.yahoo.com/news/full-transcript-seastar-medical-holding-212042506.html", "source_name": "Benzinga", "published_at": "2026-05-13T21:20:42+00:00", "published_display": "13 May 2026 21:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar device data suggest fewer child kidney deaths in early use", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQbkpvMGVhdGZOdlBvYVN1b0VNZGlCRjZORkR5T1lwTTFVY3lUVWZhSEdWdXkxOWtlY1JRNV9WVXRMY1FISFBQbWNxN0pMRWMxU01tZUNLSlgwd3l2SmxBd2xGc3h1a2txb1JkQllRTWpJd0dUMnRkWVdXQ0RybmFWLW1rWTlZRUdRSEE3MzJUZWNRZUF4NFh5YlAzNXhNSGJJcmtVNDR2djFoRWY0U1BuQV9oVDI?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Implied Volatility Surging for ICU Medical Stock Options", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPU3EyenkxUTdLZm53Qlp6ZjRMX2J3UUJVaVEzd2FBcjV6bTJUT25NdzczSWpqSFFJVjE0WHVIeGc3dUVUbGRDZzExYlN1cm11Sm8wbjlfNUJhNlBqV3p3ZVk5VGhrRVA2UXExeFROUU9aWEJBZmVWY2JickxEeElUZ3E2TWRWUU9BcVJtajM4U05LX19IZXVnSFh6T3VjZ2JsRF94MTJNVQ?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOMHZhOWJhTGNOYlFHazhRaW1Cb3I1M01IQVFrZExhRk8tTWk3QmM3MFFnSXBGV1lIRXIxeVluRk1EaERHdTUzVHRZSEFyRzZLVmJCRVJlS0RTWlFyakRqNWExVDUzSm1ZUWxVZkxSdzdmWk5HV1o0MzQwY2d1S1RGUTBjOTlNeVc3dkQwd2NyYk9VMFZEUmt6LQ?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical sets May 13 webcast for Q1 results and update", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQcnFQTkZRQUFnODFHeEphZWJWX0tDcEo1Vks5aXVHTXNXRldjRmVxN2hFd1oxeExfcVFsUUt1NTctTk1XYldIelJUd1JHNDlIaDNWR1JpY05TTUhmX0wtdk9TOVhKZlNoSWhfTm8yTXk2enN5aGt3bnQ1ZjREWDJOQ0ZHVW5ZblhNQk5FcF9EMUwxMEd1eUdPS0FuSVU3TVp4VHo2aV84Y3NPVTg3bFZPX2JiOTBJRGZPNUNMT3ZqZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQbzBJT3c3X3RKczlqVkpoLVY4MGdVZXN4VnlnWkZycWx3XzdiVlNhTTNaTjE3N005TGJEWVgyNTM0d2hVYTlsdUQxZU1za1pHVm5SR3pkWUtyaHMyU3VVSWJsWXhKVWMydllsVjYtdG41aWpDX3MzR0RWa2pxNXRBcldaMDFrWk1sVnpKb21xRnlYUzFROUpmbDN3?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "13 more children's hospitals adopt SeaStar therapy as AKI trial tops 50%", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPamljZFl3UE9kbXZFdnlnZXhYUEI2dG13aThFSUE1NXVJY3ozTDU5YjUzWW8wV3hwRjJZa3U0cHloNFpTS2tPWnMxR0N6anhuOHptMHBmUWowOGRIUk1RWlNsSjd2RTh5eFluZlVmcGNxX3lDWUpwM1VWNkVuZHFDRk5xbDhaalR2ZlU4REJzZmZ2bGNScGVsNDR4QUpULTJPVmROMXhfRFliYVhnSXF2dnJIYlhmcDFRVTlSWG1tSQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The ICU Medical (ICUI) Investment Story Is Evolving With 2026 Guidance And Analyst Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNbjZJTWNZcnZmbnJhMXRPOWFMMFNuQ2xYQ3o3N1hDUTVuNVdicDNPeGxMdkl4ZFNiV08zNGY3OXFfOVFuU3diRXZCSTZ4NUVzVHd0blNSYWwwXzVxUzJoV3J4RUdCUkdfNnJQeURoUEhCNnBITHc2dk5FVXNGWkxIcEZ4dm9lSHU4QzQ1Y2lBaXMwS1AzQWNiM3B1dFBUdmc?oc=5", "source_name": "Market source", "published_at": "2026-03-22T07:00:00+00:00", "published_display": "22 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $ICU", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBqbEN5d2RTbXA4aWw5ZHh5UEZBbW5Ja054N3NxWFB5SnJYNXdvaF82TzFsdU5DUU93aDB2QzdHY01YOXNBZ1M2OElTX3FHQ0h5clpmcV9wV2JTRWJkM0x1M1Q5bDFfQ2c?oc=5", "source_name": "MarketBeat", "published_at": "2025-07-09T20:09:50+00:00", "published_display": "09 Jul 2025 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical Holding (ICU) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE8zSjgxbFdKNUMzLU9xeHEzWU1XQzgyQnJnci1qajZGaTlKaFpXWk1ad3FwYjFpOEZ1SFF0Nlp3cUh5czcxdkVJcEpKX2ZqbEtJYkE?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T01:46:39+00:00", "published_display": "25 Apr 2025 01:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SEASTAR ALERT: Bragar Eagel & Squire, P.C. Announces that a", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "GlobeNewswire", "published_at": "2024-07-09T07:00:00+00:00", "published_display": "09 Jul 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SeaStar Medical (ICU) Stock Price, News & Analysis $ICU", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE96ZUdPcjJIUXNyaW1FSjg1c2xKeDZZQjNSbVVQdHhmWDFLOENfWk9XYURseERCUktxVDdCdWMwS054MS1DZEJ1TkVFcnZiV2xMeFcwM3pxT3E?oc=5", "source_name": "MarketBeat", "published_at": "2022-11-02T10:02:15+00:00", "published_display": "02 Nov 2022 10:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWWM3V1pmZzdlY1llRTljQmNLQ2UwdDdQaFVEcng2WVdrNE9qNzRrNVpBVlJNMGltQUhBUG1qellCVHNiM09fUkFHRW1kMEpvazJoLU11N3c4YnlWUXpmVl82aWNKeTA4U1RwSHNNSVd4d0lwWHRJclQ2TGNHWUpBQTgzbTBMVk05VGxYN0RwcmpTYklOQUFSWDhsSHZlQVpndmlPRGNvTmRmeHNILWg4ZE5jMjRoN01XNENiaVU2UDUyOWJfYUZCTm5URmtwTHJsTjJYNHo3RkxsQjBSMnBmdVZVWkFwN2PSAewBQVVfeXFMT3htM016bEt0TTdyOXE2amppMGpubTNfOFU4cGpxd2dFZkJDTjR3c0ZqOHpHYWZoamNLdmkxVmNYNklxTEM4NTU0bDZwUTZ1SW5Jc1c4NmRJN3lKQUVqUUNYYWptd2ZYNE9TeEhMRzFvbEt0bjk1TVhyVG44UnJnNDllTlFsalJVUTZwcEEzWXljbzdaQXdWWDlHQW56bGxqeG90UlFmaFFLekJlUlNIOVE4SGNHcE9pOW1KSllleVdwNERiaVl2NmxtNTNyaUtnSFY1VHUzcDJsWE9xb3R1ajZ2RGhkXzJzTldMOVA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 96, "total_relevant": 61, "sentiment_summary": {"positive": 13, "negative": 2, "neutral": 46, "score": 54, "total": 61, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 16.5, "count": 30}, {"event": "earnings", "label": "Earnings", "weight": 10.31, "count": 21}, {"event": "macro", "label": "Macro sensitivity", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 13, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 4.0, "latest_week": "2026-07-17", "one_week_move": -19.2, "four_week_move": 28.2, "twelve_week_move": -3.1, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.276671, "market_dynamics_buy_signal": false, "relative_strength": -20.377986, "fair_value_gap": -92.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 45.8035, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-19.2% over one week, +28.2% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 17}, {"label": "Market source", "count": 15}, {"label": "TradingKey", "count": 9}, {"label": "Investing.com", "count": 4}, {"label": "simplywall.st", "count": 4}, {"label": "GlobeNewswire", "count": 2}, {"label": "MarketBeat", "count": 2}, {"label": "Investing.com Canada", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 52}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 30}, {"label": "Earnings", "count": 21}, {"label": "Macro sensitivity", "count": 2}, {"label": "Balance sheet", "count": 2}, {"label": "Deals and strategy", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "52", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-19.2% over one week, +28.2% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "KeyBanc raises ICU Medical stock price target on pump growth"}], "updated_at": "2026-07-24T14:13:22.798247+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}